Loading clinical trials...

Safety and Immunogenicity of AdCOVID in Healthy Adults (COVID-19 Vaccine Study) | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 1NCT04679909

Safety and Immunogenicity of AdCOVID in Healthy Adults (COVID-19 Vaccine Study)

A study to evaluate the immune response and safety of AdCOVID administered as an intranasal spray in healthy adults.

Lead sponsor: Altimmune, Inc.•6 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGNA

The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure

NCT05545306 · Obesity, Normal Physiology, and more

RECRUITING

Turkish Adaptation of the CSQ-VR

NCT07247773 · Healthy Volunteers

RECRUITINGPhase 1/2

A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

NCT06649110 · Healthy Volunteers, Pulmonary Arterial Hypertension

RECRUITINGPhase 1

Phase I Study of HXN6005 in Adult Healthy Participants

NCT07449741 · Healthy Volunteers (HV)

RECRUITING

Cytapheresis of Volunteer Donors

NCT00104325 · Healthy Volunteers

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 14, 2023Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment92

Start dateFeb 2021

Last updatedAug 14, 2023

Condition

Healthy Volunteers

Locations shown

AGA Clinical Trials

Hialeah, Florida

Optimal Research

Melbourne, Florida

Optimal Research

Peoria, Illinois

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 14, 2023Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions